This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.
- Anti–interferon gamma (IFN-γ) autoantibody
- Mycobacterium aviumcomplex (MAC)
- disseminated Mycobacterium aviumcomplex infection
- hepatobiliary infection
ASJC Scopus subject areas
- Infectious Diseases